Since multiple studies have shown that pathological angiogenesis is a critical aspect of the onset and progression of IBD, researchers proposed the hypothesis that the anti-angiogenic factor endostatin should exert a protective effect on IBD. This evidence concerns the gene COL18A1 and inflammatory bowel disease.